Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Eric H Sasso"'
Autor:
Eric H Sasso, Brent Mabey, Darl D Flake, Elena Hitraya, Cheryl L Chin, Rotem Ben-Shachar, Alexander Gutin, Jerry S Lanchbury, Jeffrey R Curtis
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0296459 (2024)
BackgroundA multi-biomarker disease activity (MBDA)-based cardiovascular disease (CVD) risk score was developed and internally validated in a Medicare cohort to predict 3-year risk for myocardial infarction (MI), stroke or CVD death in patients with
Externí odkaz:
https://doaj.org/article/718242e5187d45599d8ba80e9b560ebb
Autor:
Marjan Ghiti Moghadam, Femke B G Lamers-Karnebeek, Harald E Vonkeman, Peter M Ten Klooster, Janneke Tekstra, Annemarie M Schilder, Henk Visser, Eric H Sasso, David Chernoff, Willem F Lems, Dirk-Jan van Schaardenburg, Robert Landewe, Hein J Bernelot Moens, Timothy R D J Radstake, Piet L C M van Riel, Mart A F J van de Laar, Tim L Jansen, Dutch National POET Collaboration
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0192425 (2018)
Successfully stopping or reducing treatment for patients with rheumatoid arthritis (RA) in low disease activity (LDA) may improve cost-effectiveness of care. We evaluated the multi-biomarker disease activity (MBDA) score as a predictor of disease rel
Externí odkaz:
https://doaj.org/article/931061a4243b42b79f19e460a8f6321b
Autor:
Jeffrey R. Curtis, Michael E. Weinblatt, Nancy A. Shadick, Cecilie H. Brahe, Mikkel Østergaard, Merete Lund Hetland, Saedis Saevarsdottir, Megan Horton, Brent Mabey, Darl D. Flake, Rotem Ben-Shachar, Eric H. Sasso, T. W. Huizinga
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-13 (2021)
Abstract Background The multi-biomarker disease activity (MBDA) test measures 12 serum protein biomarkers to quantify disease activity in RA patients. A newer version of the MBDA score, adjusted for age, sex, and adiposity, has been validated in two
Externí odkaz:
https://doaj.org/article/a68bd6514c204a78b19a9246e570fa59
Autor:
Jeffrey R. Curtis, Fenglong Xie, Cynthia S. Crowson, Eric H. Sasso, Elena Hitraya, Cheryl L. Chin, Richard D. Bamford, Rotem Ben-Shachar, Alexander Gutin, Darl D. Flake, Brent Mabey, Jerry S. Lanchbury
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-16 (2020)
Abstract Background Rheumatoid arthritis (RA) patients have increased risk for cardiovascular disease (CVD). Accurate CVD risk prediction could improve care for RA patients. Our goal is to develop and validate a biomarker-based model for predicting C
Externí odkaz:
https://doaj.org/article/820d16f7ed664ae9a9f478596526797d
Autor:
Mikkel Østergaard, Merete Lund Hetland, Xingbin Wang, Cecilie Heegaard Brahe, Saedis Saevarsdottir, Jeffrey R. Curtis, Eric H. Sasso, K. Hambardzumyan, Twj Huizinga, Darl D. Flake
Publikováno v:
Curtis, J R, Brahe, C H, Østergaard, M, Lund Hetland, M, Hambardzumyan, K, Saevarsdottir, S, Wang, X, Flake Ii, D D, Sasso, E H & Huizinga, T W 2019, ' Predicting risk for radiographic damage in rheumatoid arthritis : comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies ', Current Medical Research and Opinion, vol. 35, no. 9, pp. 1483-1493 . https://doi.org/10.1080/03007995.2019.1585064
Current Medical Research and Opinion
Current Medical Research and Opinion
Objective: To compare the multi-biomarker disease activity (MBDA) score with the DAS28-CRP and CRP for predicting risk of radiographic progression in patients with rheumatoid arthritis. Methods: Published studies of the MBDA score and radiographic pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0821a34682e4340adc1ecae74b11a777
https://doi.org/10.1080/03007995.2019.1585064
https://doi.org/10.1080/03007995.2019.1585064
Autor:
Carol J. Etzel, Elena Hitraya, Michael E. Weinblatt, Eric H. Sasso, Jeffrey R. Curtis, Nancy A. Shadick, Alexander Gutin, Daniel E. Furst, Xingbin Wang, Merete Lund Hetland, Jerry S. Lanchbury, Darl D. Flake, Mikkel Østergaard, Dimitrios A. Pappas, C.C. Hwang, Yong Gil Hwang, Cecilie Heegaard Brahe, Vibeke Strand
Publikováno v:
Rheumatology (Oxford, England)
Curtis, J R, Flake, D D, Weinblatt, M E, Shadick, N A, Østergaard, M, Hetland, M L, Brahe, C H, Hwang, Y G, Furst, D E, Strand, V, Etzel, C J, Pappas, D A, Wang, X, Hwang, C C, Sasso, E H, Gutin, A, Hitraya, E & Lanchbury, J S 2019, ' Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis ', Rheumatology, vol. 58, no. 5, pp. 874-883 . https://doi.org/10.1093/rheumatology/key367
Curtis, J R, Flake, D D, Weinblatt, M E, Shadick, N A, Østergaard, M, Hetland, M L, Brahe, C H, Hwang, Y G, Furst, D E, Strand, V, Etzel, C J, Pappas, D A, Wang, X, Hwang, C C, Sasso, E H, Gutin, A, Hitraya, E & Lanchbury, J S 2019, ' Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis ', Rheumatology, vol. 58, no. 5, pp. 874-883 . https://doi.org/10.1093/rheumatology/key367
Objective To develop and evaluate an adjusted score for the multi-biomarker disease activity (MBDA) test to account for the effects of age, sex and adiposity in patients with RA. Methods Two models were developed to adjust MBDA score for age, sex and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0fef7ca3b26e53ff62522abe7b5532e
https://doi.org/10.1093/rheumatology/key367
https://doi.org/10.1093/rheumatology/key367
Autor:
Jeffrey R. Curtis, Mikkel Østergaard, Brent Mabey, Michael E. Weinblatt, M. Horton, Eric H. Sasso, Rotem Ben-Shachar, Merete Lund Hetland, Cecilie Heegaard Brahe, Twj Huizinga, Saedis Saevarsdottir, Darl D. Flake, Nancy A. Shadick
Publikováno v:
Curtis, J R, Weinblatt, M E, Shadick, N A, Brahe, C H, Østergaard, M, Hetland, M L, Saevarsdottir, S, Horton, M, Mabey, B, Flake, D D, Ben-Shachar, R, Sasso, E H & Huizinga, T W 2021, ' Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis : a combined analysis of multiple studies ', Arthritis Research and Therapy, vol. 23, no. 1, 1 . https://doi.org/10.1186/s13075-020-02389-4
Arthritis Research & Therapy
Arthritis Research and Therapy, 23(1). BMC
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-13 (2021)
Arthritis Research & Therapy
Arthritis Research and Therapy, 23(1). BMC
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-13 (2021)
Background The multi-biomarker disease activity (MBDA) test measures 12 serum protein biomarkers to quantify disease activity in RA patients. A newer version of the MBDA score, adjusted for age, sex, and adiposity, has been validated in two cohorts (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ed090d6e9a7db3bb31796535607299
https://curis.ku.dk/portal/da/publications/validation-of-the-adjusted-multibiomarker-disease-activity-score-as-a-prognostic-test-for-radiographic-progression-in-rheumatoid-arthritis(a034cad3-96d2-42f7-9194-da98d316eb04).html
https://curis.ku.dk/portal/da/publications/validation-of-the-adjusted-multibiomarker-disease-activity-score-as-a-prognostic-test-for-radiographic-progression-in-rheumatoid-arthritis(a034cad3-96d2-42f7-9194-da98d316eb04).html
Autor:
Wan Li, Margaret H. Y. Ma, Andrew P. Cope, Eric H. Sasso, David Scott, Fowzia Ibrahim, Nadine Defranoux
Publikováno v:
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-12 (2020)
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-12 (2020)
Background Reliable assessment of remission is important for the optimal management of rheumatoid arthritis (RA) patients. In this study, we used the multi-biomarker disease activity (MBDA) test to explore the role of biomarkers in predicting point r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0e37ea143e6600d0c25e9aabc9aa49
https://pubmed.ncbi.nlm.nih.gov/32580789
https://pubmed.ncbi.nlm.nih.gov/32580789
Autor:
Frank H J van den Hoogen, Noortje van Herwaarden, Eric H. Sasso, Chantal A M Bouman, Aatke van der Maas, Alfons A den Broeder
Publikováno v:
Rheumatology, 56, 973-980
Rheumatology, 56, 6, pp. 973-980
Rheumatology, 56, 6, pp. 973-980
Item does not contain fulltext Objective.: The aim was to evaluate the predictive value of the baseline multi-biomarker disease activity (MBDA) score in long-standing RA patients with low disease activity tapering TNF inhibitors (TNFi) for successful
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9bd66c058ddbc8ed78175d11814e07
https://doi.org/10.1093/rheumatology/kex003
https://doi.org/10.1093/rheumatology/kex003
Autor:
Fenglong Xie, Elena Hitraya, Jeffrey R. Curtis, Jerry S. Lanchbury, Cynthia S. Crowson, Lang Chen, Darl D. Flake, Alexander Gutin, Cheryl Chin, Eric H. Sasso
Publikováno v:
Abstracts Accepted for Publication.
Background The ACC/AHA recommends preventive strategies for patients with a high-predicted risk of atherosclerotic cardiovascular disease (CVD). RA patients are at higher risk for CVD events, yet the role of systemic inflammation and the influence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a8f1f6e4a96b1a841045c84d1e64685
https://doi.org/10.1136/annrheumdis-2019-eular.6323
https://doi.org/10.1136/annrheumdis-2019-eular.6323